J. E. Parsons

Fluor Hanford Integrated Safety Management System Phase 1 Verification 04/12/2000 Thru 04/28/2000 Volume 1 and 2

J. E. Parsons, 2000 .

Fluor Daniel Hanford Inc. integrated safety management system phase 1 verification final report

J. E. Parsons, 1999 .

Pilot Study of the Mirabilis System Prototype for Rapid Noninvasive Uterine Myoma Treatment Using an Ultrasound-Guided Volumetric Shell Ablation Technique.

Patrick J. Martin, J. E. Parsons, M. Lau, 2017, Journal of minimally invasive gynecology.

Exploring the acoustic parameter space in ultrasound therapy: Defining the threshold for cavitational effects

J. E. Parsons, C. Cain, W. Roberts, 2007 .

Pulsed cavitational ultrasound therapy for controlled tissue homogenization.

J. E. Parsons, J Brian Fowlkes, Charles A Cain, 2006, Ultrasound in medicine & biology.

Acoustic Backscatter Features Associated with Production of Tissue Homogenate using Pulsed Cavitational Ultrasound Therapy

J. E. Parsons, C. Cain, J. Fowlkes, 2006 .

Characterizing Pulsed Ultrasound Therapy for Production of Cavitationally‐Induced Lesions

J. E. Parsons, C. Cain, J. Fowlkes, 2005 .

Cost-effective assembly of a basic fiber-optic hydrophone for measurement of high-amplitude therapeutic ultrasound fields.

J. E. Parsons, J Brian Fowlkes, Charles A Cain, 2006, The Journal of the Acoustical Society of America.

Refining histotripsy: defining the parameter space for the creation of nonthermal lesions with high intensity, pulsed focused ultrasound of the in vitro kidney.

J. E. Parsons, C. Cain, W. Roberts, 2007, The Journal of urology.

Spatial variability in acoustic backscatter as an indicator of tissue homogenate production in pulsed cavitational ultrasound therapy

J. E. Parsons, C. Cain, J. Fowlkes, 2007, IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control.